Open access · US-GOV via ClinicalTrials.gov Clinical trial

Comparison of Different Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients, and Assessment of Therapeutic Efficacy and Toxicity in Fit and Frail Patients. A Multicenter Observational Belgian Study.

Authors not listed

Universitaire Ziekenhuizen KU Leuven · 2017

Dysbiosis Human Randomized controlled trial

Abstract

The purpose of this study is to compare clinical judgment and comprehensive geriatric assessment as screening tools for optimization of treatment for newly diagnosed elderly multiple myeloma patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-13 MST

Cite this

APA

Anonymous. (2017). Comparison of Different Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients, and Assessment of Therapeutic Efficacy and Toxicity in Fit and Frail Patients. A Multicenter Observational Belgian Study. <em>Universitaire Ziekenhuizen KU Leuven</em>. https://clinicaltrials.gov/study/NCT02918695

Vancouver

Anonymous. Comparison of Different Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients, and Assessment of Therapeutic Efficacy and Toxicity in Fit and Frail Patients. A Multicenter Observational Belgian Study. Universitaire Ziekenhuizen KU Leuven. 2017.

BibTeX

@misc{anon2017Compar, title = {Comparison of Different Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients, and Assessment of Therapeutic Efficacy and Toxicity in Fit and Frail Patients. A Multicenter Observational Belgian Study.}, author = {Anonymous}, journal = {Universitaire Ziekenhuizen KU Leuven}, year = {2017}, }